You are here » Home » Companies » Company Overview » Vanta Bioscience Ltd

Vanta Bioscience Ltd.

BSE: 540729 Sector: Others
NSE: N.A. ISIN Code: INE695X01011
BSE 14:36 | 25 Jan 127.50 6.50
(5.37%)
OPEN

112.00

HIGH

127.50

LOW

112.00

NSE 05:30 | 01 Jan Vanta Bioscience Ltd
OPEN 112.00
PREVIOUS CLOSE 121.00
VOLUME 10500
52-Week high 195.50
52-Week low 105.00
P/E 177.08
Mkt Cap.(Rs cr) 80
Buy Price 115.80
Buy Qty 750.00
Sell Price 138.00
Sell Qty 750.00
OPEN 112.00
CLOSE 121.00
VOLUME 10500
52-Week high 195.50
52-Week low 105.00
P/E 177.08
Mkt Cap.(Rs cr) 80
Buy Price 115.80
Buy Qty 750.00
Sell Price 138.00
Sell Qty 750.00

Vanta Bioscience Ltd. (VANTABIOSCIENCE) - Company History

Vanta Bioscience Limited was originally incorporated as a private limited company on 29th April 2016 with the name 'Vanta Bioscience Private Limited'. The Company was converted into a public limited company and consequently the name of the Company was changed to 'Vanta Bioscience Limited' on 17th March 2017.The Promoters of the Company are Mohan Krishna Mulakala Dopesh Raja Mulakala Dr. Vyasmurti Madhavrao Shingatgeri Dr. Soumya Simhadri Shravan Chintapatla Karishma Mulakala Sajan Kiran Mulakala Pradeep Chowdary and Dr. Chandrasekhar Rao Simhadri.Vanta Bioscience(VBS) is a preclinical contract research organization offering a host of preclinical safety assessment services for clientele from Pharmaceutical Medical Devices Nutraceuticals Feed Additive Biotech Agrochemicals Cosmetics and Chemical industries. In addition it also provides risk assessment services for evaluatingthe safety of the Active Pharmaceutical Ingredients (API) excipients extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBS also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers.VBS entered into an asset transfer agreement dated February 18 2016 with Kemin Industries South Asia Private Limited Chennai for the purchase of fully operational toxicology facility Vanta Bioscience' situated at Plot K2B SIPCOT Industrial Estate Gummidipundi Chennai. The Company has taken possession of the said preclinical CRO facility at Gummidipundi Chennai and has commenced commercial operations thereat from April 1 2017. Currently the company is mainly doing previous pending research work and are also getting new work from existing clients of Vanta Bioscience' erstwhile division of Kemin Industries South Asia Private Limited. One of the major services of VBS is conducting variety of in vitro (cell tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology chemistry and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical biological and physical agents in biological systems that establish the extent of damage in living organisms.VBS has state of the art facilities and infrastructure necessary for conduct of all kind of toxicology studies for Chemicals Pharmaceuticals Cosmetics Agrochemicals like Pesticides Insecticides Excipients Novel Feed Additives. The data generated from these studies are submitted to regulatory agencies worldwide before they are put in use for the consumption of domestic animals and human being. In addition VBS also conducts preclinical proof-of-concept (PoC) studies for novel pharmaceuticals and products intended for new indications in variety of animal models of human diseases through a robust process of validation.

.